ZIOPHARM Oncology Inc Corporate Update Conference Call Transcript
Greetings, and welcome to the ZIOPHARM Oncology Corporate Update Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Adam Levy. Thank you, Adam. You may begin.
Thank you, Paul. Good afternoon, and welcome to the special ZIOPHARM Oncology conference call and webcast. This morning, we issued a press release announcing the appointment of Kevin S. Boyle, Sr. as the company's next Chief Executive Officer effective today.
Let me remind everyone that during the call, the company may make a number of forward-looking statements, including statements regarding the potential therapeutic candidates in our development pipeline, regulatory status, financial information and business trends. Forward-looking statements are subject to numerous risks and uncertainties as described in our most recent 10-K and 10-Q filings and within other filings that we may make with the SEC from time to time. Today's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
